Evidence map›Paper›PMID 16847342›Full record

ArticleMolecular and cellular biology2006

Understanding the molecular basis of the interaction between NDPK-A and AMPK alpha 1.

Russell M Crawford, Kate J Treharne, Sandrine Arnaud-Dabernat, Jean-Yves Daniel, Marc Foretz, Benoit Viollet, Anil Mehta

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Overexpression of AMPKalpha1 Ameliorates Fatty Liver in Hyperlipidemic Diabetic Rats.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2009
    Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Russell M CrawfordDepartment of Maternal and Child Health Sciences, University of Dundee, Dundee DD1 9SY, United Kingdom.
Kate J Treharne
Sandrine Arnaud-Dabernat
Jean-Yves Daniel
Marc Foretz
Benoit Viollet
Anil Mehta
Laboratoire de Biologie du Développement · FRUniversity of Dundee · GBInserm · FRInstitut Cochin · FRNinewells Hospital · GB

Funding

Wellcome TrustWellcome Trust 075237/Z/04/Z
6 · The paper itself

Abstract

Nucleoside diphosphate kinase (NDPK) (nm23/awd) belongs to a multifunctional family of highly conserved proteins (approximately 16 to 20 kDa) including two well-characterized isoforms (NDPK-A and -B). NDPK catalyzes the conversion of nucleoside diphosphates to nucleoside triphosphates, regulates a diverse array of cellular events, and can act as a protein histidine kinase. AMP-activated protein kinase (AMPK) is a heterotrimeric protein complex that responds to the cellular energy status by switching off ATP-consuming pathways and switching on ATP-generating pathways when ATP is limiting. AMPK was first discovered as an activity that inhibited preparations of acetyl coenzyme A carboxylase 1 (ACC1), a regulator of cellular fatty acid synthesis. We recently reported that NDPK-A (but not NDPK-B) selectively regulates the alpha1 isoform of AMPK independently of the AMP concentration such that the manipulation of NDPK-A nucleotide trans-phosphorylation activity to generate ATP enhanced the activity of AMPK. This regulation occurred irrespective of the surrounding ATP concentration, suggesting that "substrate channeling" was occurring with the shielding of NDPK-generated ATP from the surrounding medium. We speculated that AMPK alpha1 phosphorylated NDPK-A during their interaction, and here, we identify two residues on NDPK-A targeted by AMPK alpha1 in vivo. We find that NDPK-A S122 and S144 are phosphorylated by AMPK alpha1 and that the phosphorylation status of S122, but not S144, determines whether substrate channeling can occur. We report the cellular effects of the S122 mutation on ACC1 phosphorylation and demonstrate that the presence of E124 (absent in NDPK-B) is necessary and sufficient to permit both AMPK alpha1 binding and substrate channeling.

Indexed as

AMP-Activated Protein KinasesAnimalsHumansIsoenzymesMiceMice, KnockoutMultienzyme ComplexesNM23 Nucleoside Diphosphate KinasesNucleoside-Diphosphate KinasePeptidesPhosphorylationProtein BindingProtein Serine-Threonine KinasesProtein SubunitsRatsAMP-Activated Protein KinasesIsoenzymesMultienzyme ComplexesNM23 Nucleoside Diphosphate KinasesNME1 protein, humanNme1 protein, mouseNucleoside-Diphosphate KinasePeptidesPRKAA1 protein, humanProtein Serine-Threonine KinasesProtein Subunits

Identifiers

PMID16847342
PMCPMC1592779
OpenAlexW2108873418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.